Last checked at 12 Jan 2017 15:00
| 12 January 2017 |
Futura Medical plc
("Futura" or "the Company")
Director / PDMR Dealing and Total Voting Rights
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has received notification of option exercises by employees and Directors over 382,962 new ordinary shares of 0.2p each in the Company ("Ordinary Shares"), at a price of 40.50 pence per share.
James Barder, Chief Executive, exercised options over 250,000 ordinary shares, of which he has sold 210,000 Ordinary Shares in the Company at a price of 55.172 pence per share. Derek Martin, Finance Director, exercised options over 100,000 Ordinary Shares in the Company which he has sold at a price of 55.172 pence per share. Tim Holland, PDMR, exercised options over 2,962 Ordinary Shares in the Company which he has sold at an average price of 55.172 pence per share.
Following these transactions James Barder and Derek Martin's interests in Ordinary Shares in the Company are as follows:
Director | Ordinary Shares | Percentage of the Company's issued share capital |
James Barder | 1,528,830 | 1.27% |
Derek Martin | 280,000 | 0.23% |
This issue of the Ordinary Shares has been satisfied via the Company's block listing. Immediately following the issue, the Company will have 120,628,682 ordinary shares in issue. Since the Company currently holds no shares in treasury, the total number of voting rights in the Company is therefore 120,628,682 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Further details are contained within the notifications below, made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
For further information please contact:
Futura Medical plc |
James Barder, Chief Executive + 44 (0) 1483 685 670 james.barder@futuramedical.com www.futuramedical.com |
|
N+1 Singer (Nominated Adviser and Broker)Aubrey Powell / Liz Yong +44 (0) 20 7496 3000 |
|
For media enquiries please contact:
|
Buchanan |
Mark Court / Sophie Cowles /Stephanie Watson + 44 (0) 20 7466 5000 |
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| James Barder | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director/ PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transactions
| (i) Exercise of options over Ordinary Shares (ii) Sale of Ordinary Shares | ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 January 2017 | ||||
f)
| Place of the transactions
| (i) Outside of trading venue (ii) XLON | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Derek Martin | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director/ PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transaction
| (i) Exercise of options over Ordinary Shares (ii) Sale of Ordinary Shares | ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 January 2017 | ||||
f)
| Place of the transactions
| (i) Outside of trading venue (ii) XLON | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Tim Holland | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transaction
| (i) Exercise of options over Ordinary Shares (ii) Sale of Ordinary Shares | ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 January 2017 | ||||
f)
| Place of the transactions
| (i) Outside of trading venue (ii) XLON | ||||